Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001120:Arginine / Q000138:chemical synthesis* / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002855:Chromatography, Thin Layer; D004590:Electrophoresis, Paper; D005260:Female; D006639:Histidine / Q000138:chemical synthesis* / Q000494:pharmacology; D066298:In Vitro Techniques; D007532:Isoleucine / Q000138:chemical synthesis* / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D014443:Tyrosine / Q000138:chemical synthesis* / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects
D007532:Isoleucine; D000804:Angiotensin II; D014443:Tyrosine; D006639:Histidine; D001120:Arginine